Trialbee, a Malmö, Sweden and Chapel Hill, North Carolina-based global technology provider for patient matching and engagement in clinical trials, raised €11m in funding.
Backers included strategic investor MTIP, and existing investors Industrifonden and Briban Invest. This latest round brings the total amount raised by Trialbee to date to €25m.
The company intends to use the funds to further accelerate its topline growth and enhance its platform.
Led by Lollo Eriksson, CEO, Trialbee provides a technology platform, which integrates real world data and real time analytics to recruit and engage patients. The solution is proven to accelarate the patient recruitment process and maintain patient engagement by incorporating data-driven digital solutions in clinical trials and optimizing protocol design and site selection. Integrated patient matching from claims data, electronic health records and digital outreach to the general public are capabilities that enable Trialbee to provide additional services such as the assessment of patient feasibility, principal investigator identification and support for observational research.